Your browser doesn't support javascript.
loading
Comparison of Levetiracetam Dosing Regimens in End-Stage Renal Disease Patients Undergoing Intermittent Hemodialysis.
Shiue, Harn J; Taylor, Maria; Sands, Kara A.
Affiliation
  • Shiue HJ; 1 Mayo Clinic Hospital, Phoenix, AZ, USA.
  • Taylor M; 2 University of Alabama at Birmingham Hospital, AL, USA.
  • Sands KA; 2 University of Alabama at Birmingham Hospital, AL, USA.
Ann Pharmacother ; 51(10): 862-865, 2017 Oct.
Article in En | MEDLINE | ID: mdl-28582998
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piracetam / Seizures / Renal Dialysis / Kidney Failure, Chronic / Anticonvulsants Type of study: Etiology_studies / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piracetam / Seizures / Renal Dialysis / Kidney Failure, Chronic / Anticonvulsants Type of study: Etiology_studies / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States